Anti-MAO-A monoclonal antibody

Pre-made anti-MAO-A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MAO-A/MAOA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0006-Ab-1/ GM-Tg-hg-IP0006-Ab-2Anti-Human MAO-A/MAOA monoclonal antibodyHuman
GM-Tg-rg-IP0006-Ab-1/ GM-Tg-rg-IP0006-Ab-2Anti-Rat MAO-A/MAOA monoclonal antibodyRat
GM-Tg-mg-IP0006-Ab-1/ GM-Tg-mg-IP0006-Ab-2Anti-Mouse MAO-A/MAOA monoclonal antibodyMouse
GM-Tg-cynog-IP0006-Ab-1/ GM-Tg-cynog-IP0006-Ab-2Anti-Cynomolgus/ Rhesus macaque MAO-A/MAOA monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0006-Ab-1/ GM-Tg-felg-IP0006-Ab-2Anti-Feline MAO-A/MAOA monoclonal antibodyFeline
GM-Tg-cang-IP0006-Ab-1/ GM-Tg-cang-IP0006-Ab-2Anti-Canine MAO-A/MAOA monoclonal antibodyCanine
GM-Tg-bovg-IP0006-Ab-1/ GM-Tg-bovg-IP0006-Ab-2Anti-Bovine MAO-A/MAOA monoclonal antibodyBovine
GM-Tg-equg-IP0006-Ab-1/ GM-Tg-equg-IP0006-Ab-2Anti-Equine MAO-A/MAOA monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg

Product Description

Catalog No.GM-Tg-hg-IP0006-Ab-1/ GM-Tg-hg-IP0006-Ab-2; GM-Tg-rg-IP0006-Ab-1/ GM-Tg-rg-IP0006-Ab-2;
GM-Tg-mg-IP0006-Ab-1/ GM-Tg-mg-IP0006-Ab-2; GM-Tg-cynog-IP0006-Ab-1/ GM-Tg-cynog-IP0006-Ab-2;
GM-Tg-felg-IP0006-Ab-1/ GM-Tg-felg-IP0006-Ab-2; GM-Tg-cang-IP0006-Ab-1/ GM-Tg-cang-IP0006-Ab-2;
GM-Tg-bovg-IP0006-Ab-1/ GM-Tg-bovg-IP0006-Ab-2; GM-Tg-equg-IP0006-Ab-1/ GM-Tg-equg-IP0006-Ab-2
Products NameAnti-MAO-A/MAOA monoclonal antibody
Target NameMAO-A
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
Products descriptionPre-made anti-MAO-A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


    Data / case study

    Click to get more Data / Case study about the product.

    Associated products

    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0006-Ag-1Recombinant multi-species AOFA/ MAO-A/ MAOA protein
    ORF Viral VectorvGMLP002137human MAOA Lentivirus particle
    ORF Viral VectorpGMLP002137human MAOA Lentivirus plasmid
    ORF Viral VectorpGMLPm004342mouse Maoa Lentivirus plasmid
    ORF Viral VectorvGMLPm004342mouse Maoa Lentivirus particle

    Target information

    Target IDGM-IP0006
    Target NameMAO-A
    Gene ID4128,17161,29253,708371,403450,101091848,281293,100033867
    Gene Symbol and Synonyms1110061B18Rik,BRNRS,Mao,MAO-A,MAOA
    Uniprot AccessionP21397,P21396,P58027,P21398,Q5NU32
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    Gene EnsemblENSG00000189221
    Target ClassificationN/A

    The target: MAO-A, gene name: MAOA, also named as BRNRS, MAO-A. This gene is one of two neighboring gene family members that encode mitochondrial enzymes which catalyze the oxidative deamination of amines, such as dopamine, norepinephrine, and serotonin. Mutation of this gene results in Brunner syndrome. This gene has also been associated with a variety of other psychiatric disorders, including antisocial behavior. Alternatively spliced transcript variants encoding multiple isoforms have been observed. [provided by RefSeq, Jul 2012].

    About Gmab


    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.